Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Reneo Pharmaceuticals Inc
(NQ:
RPHM
)
1.430
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Reneo Pharmaceuticals Inc
< Previous
1
2
Next >
Reneo Pharmaceuticals Announces Presentation and Posters at Mitochondrial Medicine Symposium 2023
June 15, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Update -- Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
May 31, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate at the Jefferies Healthcare Conference
May 31, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Reports First Quarter 2023 Financial Results
May 11, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Announces Pricing of Public Offering of Common Stock
May 03, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 03, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 27, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Achieves Target Enrollment in the Pivotal STRIDE Study of Mavodelpar (REN001) in Primary Mitochondrial Myopathies
March 14, 2023
Topline data from the STRIDE study expected in the fourth quarter of 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Present Preclinical Mavodelpar (REN001) Data at the Society for Inherited Metabolic Disorders Annual Meeting 2023
March 09, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference
February 02, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Receives Fast Track Designation from the FDA for Mavodelpar (REN001) in a Genotype of Long-Chain Fatty Acid Oxidation Disorder (LC-FAOD)
January 31, 2023
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 08, 2022
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals to Participate at Upcoming Investor Conferences
November 03, 2022
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
Reneo Pharmaceuticals Reports Positive Results from REN001 Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Study and Provides Additional Development Updates
July 26, 2022
From
Reneo Pharmaceuticals, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.